Senseonics Gets FDA Approval for Eversense Implantable CGM System

Eversense Implantable CGM System
Senseonics, a company that develops implantable continuous glucose monitoring (CGM) system for people with diabetes, received FDA approval for the non-adjunctive indication (dosing claim) for its Eversense CGM. Related Nemaura’s SugarBeat Non-Invasive CGM Gets CE Approval The CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, […]